Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Sevilla 2012
NDICE
Introduccin.
Envejecimiento. Clulas Madre. ADSC.
Resultados y Discusin.
Conclusiones.
ENVEJECIMIENTO BIOLGICO
Prdida progresiva de las f(x) ptimas de un organismo con el paso de los aos.
Consecuencia de factores intrnsecos y extrnsecos.
CELULAS MADRE
2 Propiedades esenciales:
Tipos:
CELULAS MADRE
Ventajas e Inconvenientes:
Ventajas Inconvenientes
ESC
Proliferacin Pluripotencialidad
Tumorognesis T. Autlogo No P. ticos T. Autlogo No P. ticos
ASC
iPSC
ADSC
Fcil acceso Anestesia local Molestias para el paciente Abundancia No problemas ticos
Optimizar la extraccin, cultivo y mantenimiento de MSC adultas de lipoaspirado humano Banco Celular. Estudio del cumplimiento de criterios del Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy. Puesta a punto un mtodo de obtencin de CM de tejido adiposo de rata. Elegir aquellas condiciones que menos afecte la viabilidad celular tras la descongelacin.
Como se afecta por HC la viabilidad, la citotoxicidad y la capacidad de diferenciacin de las CM de rata. Accin protectora de la melatonina frente al HC. Conocer si la vulnerabilidad de las CM humanas por parte del HC vara entre personas y depende de la edad. Desarrollar un mtodo para seguimiento de las CM in vivo. el marcaje y
PLAN DE TRABAJO
ENSAYOS
Efecto de la criopreservacin sobre la viabilidad. Efecto sobre la citotoxicidad y viabilidad de ADSC tratadas con HC Efecto del HC y la melatonina sobre la capacidad de diferenciacin Efecto protector de melatonina Mecanismo de muerte celular tras el tratamiento con HC Efecto citotxico HC sobre CM de diferentes pacientes
Transfeccion de ADSC de rata con lentivirus Seguimiento de las clulas trasplantadas por imgenes de bioluminiscencia ptica
Muestras acuosa
Lavado
Centrifugado
Eliminacin
fase
Filtrado (100 m)
Obtencin de la SVF
Digestin con
Centrifugado
Lisis de Eritrocitos
Marcaje con Ig
Criopreservacion
Incubacin
Cultivo
Separacin
Criterios para las MSC (Mesenchymal and Tissue Stem Cell Committee of the International Society):
Adherentes al plstico.
Test de Adhesin
ADSCh ADSCr
Test de multipotencialidad
Adipocitos
Osteoblastos
Test de multipotencialidad
ADSCh
Adipocitos Osteoblastos
ADSCr
Adipocitos
Test de fenotipado
Cocktail para fenotipado de MSC humanas: Anticuerpos monoclonales conjugados con fluorforos:
CD105-PE
CD14,
CD20,CD34 y CD45- PerCP
CD90.1-FITC
Mtodo Colorimtrico
Viabilidad
Viabilidad
Citotoxicidad
Criopreservacin
Medio+
24
h a - 80 C N. Liquido
20 M de HC 3 h
Viabilidad
Teir
anexina-V-FITC PI
Teir
Anexina-V-FITC PS. Marcador de Apoptosis. PI ADN/ ARN. Marcador de Necrosis.
10M HC
20M HC
40M HC
Da
tras
el
Zona
Bioluminiscencia (p/s/cm2/sr)
trasplante DIA 1 MANO CABEZA DIA 4 MANO CABEZA DIA 8 MANO CABEZA
08
05
06
04
06
05
CONCLUSIONES
Las ADSC obtenidos cumplen los requisitos como MSC. 10 % DMSO ptima para la congelacin. El HC afecta la viabilidad, la citotoxicidad y la diferenciacin de las ADSC, ejerciendo la melatonina un papel protector. Las ADSC de pacientes de ms edad parecen ser ms sensibles al HC.
Sistema de anlisis de imagen in vivo, pudimos observar que las clulas transfectadas con el gen de la luciferasa y trasplantadas en animales fueron visibles en la zona de inyeccin, dando seal, al menos, hasta el octavo da.
BIBLIOGRAFA
ARGELLES S, MUOZ MF, CANO M, Y COLS. 2012. In vitro and in vivo protection by melatonin against the decline of elongation factor-2 caused by lipid peroxidation: preservation of protein synthesis. J Pineal Res. 53(1):1-10 AVERY S, INNIS K, MOORE H. 2006. The regulation of self-renewal in human embryonic stem cells. Stem Cells Dev. 15, 729-740. AYALA, A.; CUTLER, R. G. 1997. Preferential use of less toxic detoxification pathways by long-lived species. Arch. Gerontol. Geriatr. 24, 87-102. AYALA, A., PARRADO, J., BOUGRIA, M. AND MACHADO, A. 1996. Effect of oxidative stress produced by Cumene hydroperoxide on the various step of protein synthesis. J. Biol. Chem. 271, 23105-23110. BAJADA S, MAZAKOVA I, RICHARDSON JB, ASHAMMAKHI N. 2008. Updates on stem cells and their applications in regenerative medicine. J Tissue Eng Regen Med. 2(4), 169-183. BJORKLUND LM, SANCHEZ-PERNAUTE R, CHUNG S, Y COLS. 2002. Embryonic stem cells develop into functional dopaminergic neurons after transplation in a Parkinson rat mode. Proc Natl Acad Sci USA. 99, 23442349. BURNS TC, VERFAILLIE CM AND LOW WC. 2009. Stem cells for ischemic brain injury: A critical review. J Comp Neurol. 515(1), 125-144. CARSON CT, AIGNER S, GAGE FH. 2006. Stem cells: the good, bad, and barely in control. Nat Med. 12, 12371238. CASTEILLA L, PLANAT-BENARD V, COUSIN B Y COLS. 2005. Plasticity of adipose tissue: A promising therapeutic avenue in the treatment of cardiovascular and blood diseases. Arch Mal Coeur Vaiss. 98, 922926. CHARRIRE G, COUSIN B, ARNAUD E Y COLS. 2003. Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem. 278, 9850 9855. CHMIELNICKI E, BENRAISS A, ECONOMIDES AN, GOLDMAN SA. 2004. Adenovirally expressed noggin and brain-derived neurotrophic factor cooperate to induce new medium spiny neurons from resident progenitor cells in the adult striatal ventricular zone. J Neurosici. 24, 2133-2142.
BIBLIOGRAFA
CONSTANTIN G, MARCONI S, ROSSI B, Y COLS. 2009. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells. 27, 2624-2635. DALERBA P, CHO RW, CLARKE MF. 2007. Cancer stem cell: models and concepts. Annu Rev Med. 58, 267284. DICKER A, LE BLANC K, ASTROM G Y COLS. 2005. Functional studies of mesenchymal stem cells derived from adult human adipose tissue. Exp Cell Res. 308, 283290. DOMINICI M, LE BLANC K, MUELLER I Y COLS. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 8, 315317. EBRAHIMIAN TG, POUZOULET F, SQUIBAN C, Y COLS. 2009. Cell therapy based on adipose tissue-derived stromal cells promotes physiological and pathological wound healing. Arterioscler Thromb Vasc. Biol. 29, 503510. FEHRER G, LEPPENDINGER G. 2005. Mesenchymal stem cell aging. Exp. Gerontol. 40, 926930. FINKEL, T.. HOLBROOK, N. J. 2000.Oxidants, oxidative stress and the biology of ageing 29. Nature. 408, 239247. FRASER JK, WULUR I, ALFONSO Z, HEDRICK MH. 2006. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol. 24(4),150-154. GALANO A, TAN DX, REITER RJ. 2011. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res. 51:116 GARCIA-OLMO D, HERREROS D, PASCUAL M, Y COLS. 2009. Treatment of enterocutaneous fistula in Crohn's Disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion. Int J Colorectal Dis. 24, 27-30 (a). GARCIA-OLMO D, HERREROS D, PASCUAL I, Y COLS. 2009. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum. 52, 79-86 (b). GARCIA-OLMO D, GARCIA-ARRANZ M, HERREROS D. 2008. Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn's disease. Expert Opin Biol Ther. 8, 1417-1423.
BIBLIOGRAFA
GIMBLE JM, KATZ AJ, BUNNEL BA. 2007. Adipose-derived stem cells for regenerative medicine. Circ Res. 100, 1249-1260. GONDA K, SHIGEURA T, SATO T, Y COLS. 2008. Preserved proliferative capacity and multipotency of human adipose-derived stem cells after long-term cryopreservation. Plast Reconstr Surg. 121(2), 401-410. GRONTHOS S, FRANKLIN DM, LEDDY HA Y COLS. 2001. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol. 189, 5463. GRTZKAU A, AND RADBRUCH A. 2010. Small but mighty: How the MACS-Technology based on nanosized superparamagnetic particles has helped to analyze the immune system within the last 20 years. Cytometry. 77A, 643-647. HANNA JH, SAHA K, JAENISCH R. 2010. Pluripotency and cellular reprogramming: Facts, hypotheses, unresolved issues. Cell. 143, 508-525. HARMAN, D. 1956. Aging: a theory based on free radical and radiation chemistry 27. J. Gerontol. 11, 298-300. HIPP J , ATALA A . 2008. Sources of stem cells for regenerative medicine . Stem Cell Reviews. 4, 311. HIPP, J.. ATALA, A. 2004. Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy. J. Exp. Clin. Assist. Reprod. 1, 3. HO AD, WAGNER W, MAHLKNECHT U. 2005. Stem cells and ageing. The potential of stem cells to overcome age-related deteriorations of the body in regenerative medicine. EMBO Rep. 6, 3538. HYSLOP L, STOJKOVIC M, ARMSTRONG L, Y COLS. 2005. Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages. Stem cells. 23, 1035-1043. JONES EA, ENGLISH A, KINSEY SE, STRASZYNSKI L, Y COLS. 2006 . Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry B Clin Cytom. 15.70(6), 391-399. KASAPOGLU, M.. OZBEN, T. 2001. Alterations of antioxidant enzymes and oxidative stress markers in aging. Exp. Gerontol. 36, 209-220.
BIBLIOGRAFA
KIRKWOOD, T. B. 2005. Understanding the odd science of aging. Cell 120, 437-447. KOLB B, MORSHEAD C, GONZALEZ C, Y COLS. 2007. Growth factor-stimulated generation of new cortical tissue and functional recovery after stroke damage to the motor cortex of rats. J. Cereb Blood Flow Metab. 27, 983-997. LE BLANC K, RINGDN O. 2007. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med. 262, 509-525. LEE RH, KIM B, CHOI I Y COLS. 2004. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem.14, 311324. MILTENYI S, MULLER W, WEICHEL W, RADBRUCH A. 1990. High gradient magnetic cell separation with MACS. Cytometry.11, 231238. NICOLIS SK. Cancer stemm cells and stemness genes in neuroncology. 2007. Neurobiol Dis. 25, 217-229. OEDAYRAJSINGH-VARMA M, VAN HAM S, KNIPPENBERG M Y COLS. 2006. Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy. 8, 166177. PEPTAN IA, HONG L, MAO JJ. 2006. Comparison of osteogenic potentials of visceral and subcutaneous adipose-derived cells of rabbits. Plast Reconstr Surg. 117, 14621470. PORTER, T. D.. COON, M. J. 1991. Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J. Biol. Chem. 266, 13469-13472. PRUNET-MARCASSUS B, COUSIN B, CATON D Y COLS. 2006. From heterogeneity to plasticity in adipose tissues: Site-specific differences. Exp Cell Res. 312, 727736. QUIRICI N, SOLIGO D, BOSSOLASCO P, Y COLS. 2002. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol. 30(7), 783-791. RANDO, T. A. 2006. Stem cells, ageing and the quest for immortality. Nature 441, 1080-1086.
BIBLIOGRAFA
ROSENTHAL N. 2005 .Youthful prospects for human stem-cell therapy. In another few decades, revised attitudes toward stem cells could lead to disease prevention and life extension. EMBO Rep. 6 Spec No, S30 S34. SANCHEZ P, SAN ROMAN J, VILLA A, Y COLS. 2006. Contemplating the bright future of stem cell therapy for cardiovascular Disease. Nat Clin Pract Cardiovasc Med. 3:S138151. SCHFFLER A AND BCHLER C. 2007.Concise Review: Adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells. 25, 818-827. SCHEFFLER B, SCHMANDT T, SCHRODER W, Y COLS. 2003. Functional network integration of embryonic stem cell-derived astrocytes in hippocampal slice culture. Development. 130, 5533-5541
SENGENS C, LOLMEDE K, ZAKAROFF-GIRARD A; Y COLS. 2005. Preadipocytes in the human subcutaneous adipose tissue display distinct features from the adult mesenchymal and hematopoietic stem cells. J Cell Physiol; 205, 114 122.
SMITH P, ADAMS WP JR., LIPSCHITZ AH Y COLS. 2006. Autologous human fat grafting: Effect of harvesting and preparation techniques on adipocytes graft survival. Plast Reconstr Surg. 117, 1836 1844. STOJKOVIC M, LAKO M, STRACHAN T, Y COLS. 2004.Derivation, growth and application of human embryonic stem cells. Reproduction. 128, 259-267. SUTTON EJ, HENNING TD, PICHLER BJ, BREMER C, DALDRUP-LINK HE. 2008. Cell tracking with optical imaging. Eur Radiol. 18(10):2021-32 TAKAHASHI K, TANABE K, OHNUKI M, NARITA M, ICHISAKA T, TOMODA K, YAMANAKA S. 2007. Induction of pluripotent stem cells from adult human fibroblast by defined factors. Cell. 131, 861-872. TAKAHASHI K, YAMANAKA S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 162, 663-676.
BIBLIOGRAFA
TARTE K, GAILLARD J, LATAILLADE JJ, Y COLS. 2010. Clinical grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood. 115, 1549-1553. TEO AK, VALLIER L. 2010. Emerging use of stem cells in regenerative medicine. Biochem J. 428, 1123. THOMPSON JA, ITSKOVITZ-ELDOR J, SHAPIRO SS, Y COLS. 1998. Embryonic stem cell lines derived from human blastocysts. Science. 228, 1145-1147. TROUNSON, A.; THAKAR, R.G.; LOMAX, G. & GIBBONS, D. 2011. Clinical trials for stem cell therapies. BMC Medicine. 9, 52-58. URBICH C, DIMMELER S. 2004. Endothelial progenitor cells functional characterization. Trends Cardiovasc Med. 14, 318 322. VALINA C, PINKERNELL K, SONG YH, Y COLS. 2007. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J. (21):2667-77. WAGNER W, WEIN F, SECKINGER A Y COLS. 2005. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol. 33, 14021416. YU, B. P.; YANG, R. 1996. Critical evaluation of the free radical theory of aging. A proposal for the oxidative stress hypothesis. Ann. N. Y. Acad. Sci. 786, 1-11. YU JM, WU X, GIMBLE JM, Y COLS. 2011. Age-related changes in mesenchymal stem cells derived from rhesus macaque bone marrow. Aging Cell. 10, 6679. ZUK PA, ZHU M, ASHJIAN P Y COLS. 2002. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 13, 42794295. ZUK PA, ZHU M, MIZUNO H Y COLS. 2001. Multilineage cells from human adipose tissue: Implications for cellbased therapies. Tissue Eng. 7, 211220.
MUCHAS
GRACIAS